GUGGENHEIM CAPITAL LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$278,193
-21.0%
6,049
-1.3%
0.00%
-33.3%
Q2 2023$352,119
-20.9%
6,127
-48.4%
0.00%
-25.0%
Q1 2023$444,975
-12.6%
11,866
-34.7%
0.00%0.0%
Q4 2022$509,095
+28.9%
18,169
+29.1%
0.00%0.0%
Q3 2022$395,000
-25.6%
14,073
-7.7%
0.00%0.0%
Q2 2022$531,000
-52.5%
15,244
-51.1%
0.00%
-42.9%
Q1 2022$1,118,000
+40.5%
31,155
-8.9%
0.01%
+75.0%
Q4 2021$796,000
+13.1%
34,191
-7.7%
0.00%0.0%
Q3 2021$704,000
+306.9%
37,056
+208.7%
0.00%
Q1 2017$173,000
-87.4%
12,003
-83.9%
0.00%
-100.0%
Q4 2016$1,377,000
-47.1%
74,718
-45.5%
0.00%
-50.0%
Q3 2016$2,603,000
+104.6%
137,215
+74.0%
0.01%
+100.0%
Q2 2016$1,272,000
+8.5%
78,866
-19.2%
0.00%0.0%
Q1 2016$1,172,000
-11.1%
97,665
+5.4%
0.00%0.0%
Q4 2015$1,319,000
+2.9%
92,670
-15.5%
0.00%0.0%
Q3 2015$1,282,000
-36.3%
109,641
-4.3%
0.00%
-20.0%
Q2 2015$2,014,000114,5400.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders